Casper K. Nielsen

Hellerup, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial.

Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial.

Journal: The lancet. Diabetes & endocrinology

Published: December 10, 2025

Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study.

Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study.

Journal: Diabetes

Published: October 28, 2025

Glucose-Dependent Effects of Exogenous Glucagon-Like Peptide-2 on Circulating Glucagon Levels in Healthy Men.

Glucose-Dependent Effects of Exogenous Glucagon-Like Peptide-2 on Circulating Glucagon Levels in Healthy Men.

Journal: Journal of the Endocrine Society

Published: October 06, 2025

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study.

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study.

Journal: Diabetes, obesity & metabolism

Published: September 30, 2025

Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial.

Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial.

Journal: EClinicalMedicine

Published: September 01, 2025

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.

Journal: Diabetes, obesity & metabolism

Published: August 12, 2025

Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study.

Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study.

Journal: Diabetes, obesity & metabolism

Published: August 03, 2025

Proglucagon-derived peptides: human physiology and therapeutic potential.

Proglucagon-derived peptides: human physiology and therapeutic potential.

Journal: Physiological reviews

Published: July 28, 2025

Phosphodiesterase-4 Inhibition as a Potential Therapeutic Strategy in the Management of Obesity: a Review.

Phosphodiesterase-4 Inhibition as a Potential Therapeutic Strategy in the Management of Obesity: a Review.

Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity

Published: July 04, 2025

Dietary protein restriction elevates FGF21 levels and energy requirements to maintain body weight in lean men.

Dietary protein restriction elevates FGF21 levels and energy requirements to maintain body weight in lean men.

Journal: Nature metabolism

Published: April 03, 2024

Targeting the GLP-2 receptor in the management of obesity.

Targeting the GLP-2 receptor in the management of obesity.

Journal: Peptides

Published: December 22, 2023

Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial.

Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Diabetes care

Published: June 28, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026